#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scleroderma associated digital ulcer Thrombocytosis Brain injury Neovascular age-related macular degeneration Selective polysaccharide antibody deficiency Neuroendocrine carcinoma Prophylaxis against transplant rejection Congenital growth hormone deficiency Pituitary-dependent Cushing's syndrome Mucopolysaccharidosis I Stevens-Johnson syndrome Acute promyelocytic leukaemia Cardiac amyloidosis Central nervous system lymphoma Glomerulonephritis chronic More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative Isodicentric chromosome 15 syndrome – Diagnostics Arterial tortuosity syndrome – Treatment Niemann-Pick disease – Diagnostics Alveolar rhabdomyosarcoma – Diagnostics Pituitary-dependent Cushing’s syndrome – Treatment Castleman’s disease – Diagnostics Mucopolysaccharidosis – Trials in Disease Testicular leiomyosarcoma Cytokine release syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Topiramate Amb-05X Bomedemstat Tiotropium Bromide Monohydrate Obefazimod PARECOXIB Wt1/Il15/Il15Ra Mrna Dc Cilastatin Dermatophagoides Pteronyssinus RNMB3 Mebendazole Selatogrel Bempedoic Acid Acou085 Incb099280 Alclometasone Dipropionate Colistin Sulfate Human Plasma Protein Esomeprazole Df6002 More therapies…

    Learn about Your Condition

    Breast cancer stage I Kidney transplant rejection Cervix carcinoma recurrent Renal cancer Abortion threatened Stomatitis Eczema Urticaria cholinergic Triple positive breast cancer Abdominal wall pain Hyperthyroidism Eosinophilic oesophagitis Optic atrophy Desmoid tumour Renal failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of ponatinib and azacitidine combination treatment in patients with accelerated phase or blast crisis chronic myelogenous leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Ponatinib
    France

  • Study on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
    Denmark France Germany Ireland Italy The Netherlands +1

  • Study on SENS-401 to Prevent Hearing Loss Caused by Cisplatin in Adults with Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • R-Azasetron Besilate
    France

  • Study of AMG 193 alone and combined with docetaxel for treatment of advanced MTAP-null solid tumors in adult patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Ductal adenocarcinoma of pancreas
    • Non-small cell lung cancer
    Investigated Drugs:
    • Amg 193
    Austria Belgium France Germany

  • Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    • Anifrolumab
    Austria Bulgaria Denmark France Germany Greece +7

  • Study of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Docetaxel
    • Methotrexate
    Belgium Czechia France Germany Greece Hungary +6

  • Study on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Selgantolimod
    • Entecavir
    • Tenofovir Alafenamide
    France Germany Italy Spain

  • Study on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France

  • Study on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir Sodium
    • Lenacapavir
    • Cabotegravir
    France

  • Study on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Muscle Specific Kinase
    Belgium Denmark France The Netherlands Sweden
Previous Page
1 … 11 12 13 14 15 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!